Standout Papers

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes 2023 2026 20241.1k
  1. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023)
    A. Michael Lincoff, Kirstine Brown‐Frandsen et al. New England Journal of Medicine

Immediate Impact

5 from Science/Nature 67 standout
Sub-graph 1 of 19

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Metabolic dysfunction-associated steatotic liver disease in adults
2025 Standout

Works of Sille Esbjerg being referenced

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout

Author Peers

Author Last Decade Papers Cites
Sille Esbjerg 71 270 97 779 418 8 1.3k
Thaddeus E. Prout 38 289 128 704 89 32 1.3k
Lynda Stevens 39 214 186 825 70 16 1.5k
Ambady Ramachandran 32 560 91 1421 286 9 1.5k
Michael V. Holmes 35 225 116 248 88 23 1.2k
Søren Hardt‐Lindberg 9 291 92 851 441 9 1.2k
Silvina Gallo 22 578 95 1274 175 13 1.4k
Steve Snapinn 40 98 67 527 85 11 1.5k
Katelyn Brown 11 577 118 1275 543 22 1.6k
Jennifer Green 13 360 129 1024 172 3 1.3k
Huzhang Mao 82 412 74 528 237 14 1.1k

All Works

Loading papers...

Rankless by CCL
2026